NKCx Histopathological outcome* within 12 months after cervix cytology in 2018 |
131 Eskilstuna |
Benign | CIN1 | CIN2 | CIN3 | AIS | Cancer | Other | PAD missing | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytology | Count | Pct | Count | Pct | Count | Pct | Count | Pct | Antal | Andel | Count | Pct | Count | Pct | Count | Pct | Count | Pct |
Benign sample | 93 | 0.6% | 7 | 0.0% | 1 | 0.0% | 1 | 0.0% | . | . | . | . | 2 | 0.0% | 14578 | 99.3% | 14682 | 100.0% |
ASCUS | 60 | 18.6% | 62 | 19.2% | 9 | 2.8% | 13 | 4.0% | 1 | 0.3% | . | . | 4 | 1.2% | 174 | 53.9% | 323 | 100.0% |
CIN1 | 64 | 24.3% | 88 | 33.5% | 16 | 6.1% | 30 | 11.4% | . | . | 1 | 0.4% | 2 | 0.8% | 62 | 23.6% | 263 | 100.0% |
Atypical glandular cells/AGC | . | . | 2 | 33.3% | . | . | . | . | 1 | 16.7% | . | . | 1 | 16.7% | 2 | 33.3% | 6 | 100.0% |
Unclear atypia | 1 | 7.7% | 3 | 23.1% | 2 | 15.4% | 5 | 38.5% | 1 | 7.7% | . | . | . | . | 1 | 7.7% | 13 | 100.0% |
ASC-H | 2 | 10.0% | 4 | 20.0% | 7 | 35.0% | 6 | 30.0% | . | . | . | . | . | . | 1 | 5.0% | 20 | 100.0% |
CIN2 | 1 | 9.1% | 1 | 9.1% | 1 | 9.1% | 8 | 72.7% | . | . | . | . | . | . | . | . | 11 | 100.0% |
CIN3 | 7 | 8.2% | 9 | 10.6% | 8 | 9.4% | 56 | 65.9% | . | . | 4 | 4.7% | . | . | 1 | 1.2% | 85 | 100.0% |
Adenocarcinoma | . | . | . | . | . | . | . | . | . | . | 1 | 100.0% | . | . | . | . | 1 | 100.0% |
Total | 228 | 1.5% | 176 | 1.1% | 44 | 0.3% | 119 | 0.8% | 3 | 0.0% | 6 | 0.0% | 9 | 0.1% | 14819 | 96.2% | 15404 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80413, M80703, M81401, M81403 |